Stay updated with breaking news from James Chambers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Some private insurers are balking at paying for the first drug fully approved to slow mental decline in Alzheimer’s patients. Insurers selling coverage in North Carolina, Pennsylvania and New York, among other states, told The Associated Press they won’t cover Leqembi with insurance offered on the individual market and through
Some private insurers in Pennsylvania are balking at paying for the first drug fully approved to slow mental decline in Alzheimer's patients.
Breaking News, Sports, Manitoba, Canada
Some private insurers are balking at paying for the first drug fully approved to slow mental decline in Alzheimer's patients.
Their decision stands in contrast to Medicare, which will wind up covering most patients who take the drug.